[1]高向峰,饶向荣,李深,等.肺肾同治法治疗IgA肾病[J].中国中医药信息杂志,2020,27(3):118-121.[doi:10.3969/j.issn.1005-5304.201907456]
 GAO Xiangfeng,RAO Xiangrong,LI Shen,et al.Treatment of IgA Nephropathy with Simultaneously Treating Lung-kidney Therapy[J].zhongguo zhongyiyao xinxi zazhi,2020,27(3):118-121.[doi:10.3969/j.issn.1005-5304.201907456]
点击复制

肺肾同治法治疗IgA肾病

参考文献/References:

[1] DENG W, TAN X, ZHOU Q, et al. Gender-related differences in clinicopathological characteristics and renal outcomes of Chinese patients with IgA nephropathy[J]. BMC Nephrol,2018,19(1):31.

[2] SUZUKI H, KIRYLUK K, NOVAK J, et al. The pathophysiology of IgA nephropathy[J]. J Am Soc Nephrol,2011,22(10):1795-1803.

[3] ZHAO N, HOU P, LV J, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression[J]. Kidney Int,2012,82(7):790-796.

[4] XIE J, KIRYLUK K, WANG W, et al. Predicting progression of IgA nephropathy:new clinical progression risk score[J]. PLoS One, 2012,7(6):e38904.

[5] DORVAL G, GRIBOUVAL O, MARTINEZ-BARQUERO V, et al. Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome[J]. Pediatr Nephrol,2018,33(3):473-483.

[6] LOMAX-BROWNE H J, VISCONTI A, Pusey C D, et al. IgA1 glycosylation is heritable in healthy twins[J]. J Am Soc Nephrol, 2017,28(1):64-68.

[7] ZHANG Y M, ZHOU X J, ZHANG H. What genetics tells us about the pathogenesis of IgA nephropathy:the role of immune factors and infection[J]. Kidney Int Rep,2017,2(3):318-331.

[8] AMBRUZS J M, WALKER P D, LARSEN C P. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease[J]. Clin J Am Soc Nephrol,2014,9(2):265-270.

[9] COPPO R. The gut-kidney axis in IgA nephropathy:role of microbiota and diet on genetic predisposition[J]. Pediatr Nephrol, 2018,33(1):53-61.

[10] ROLLINO C, VISCHINI G, COPPO R. IgA nephropathy and infections[J]. J Nephrol,2016,29(4):463-468.

[11] GESUALDO L, LAMM M E, EMANCIPATOR S N. Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization[J]. J Immunol,1990,145(11):3684-3691.

[12] MCCARTHY D D, KUJAWA J, WILSON C, et al. Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy[J]. J Clin Invest,2011,121(10):3991-4002.

[13] CERUTTI A. The regulation of IgA class switching[J]. Nat Rev Immunol,2008,8(6):421-434.

[14] MAGISTRONI R, D’AGATI V D, APPEL G B, et al. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy[J]. Kidney Int,2015,88(5):974-989.

[15] 占永立,戴希文.益气活血、清热利湿法为主治疗慢性肾炎30例临床观察[J].中医杂志,2003,44(12):922-924.

[16] 许朝进,席孝贤,贺新怀.卫气与黏膜免疫相关性辨识[J].中医药学刊,2005,23(1):120-123.

[17] YEO S C, CHEUNG C K, BARRATT J. New insights into the pathogenesis of IgA nephropathy[J]. Pediatr Nephrol,2018,33(5):763-777.

[18] BUREN M, YAMASHITA M, SUZUKI Y, et al. Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy[J]. Contrib Nephrol,2007,157:50-55.

[19] SAHA M K, JULIAN B A, NOVAK J, et al. Secondary IgA nephropathy[J]. Kidney Int,2018,94(4):674-681.

[20] GHARAVI A G, KIRYLUK K, CHOI M, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy[J]. Nat Genet,2011,43(4):321-327.

[21] JIANG S H, KENNARD A L, WALTERS G D. Recurrent glomerulonephritis following renal transplantation and impact on graft survival[J]. BMC Nephrol,2018,19(1):344.

[22] 张松青,饶向荣,戴希文.益气清解方治疗IgA肾病的临床疗效观察[J].光明中医,2006,21(12):44-45.

[23] 饶向荣,白雅雯.戴希文治疗IgA肾病的经验[J].北京中医药,2008, 27(9):691-693.

[24] LAI K N, LEUNG J C, CHAN L Y, et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy[J]. Nephrol Dial Transplant,2009,24(1):62-72.

[25] 程小红,于小勇,毛加荣.IgA肾病的病理改变与中医微观辨证[J].中国中西医结合肾病杂志,2014,15(2):185-186.

相似文献/References:

[1]邵治国,邓晓兰.中西医结合治疗IgA肾病临床观察[J].中国中医药信息杂志,2009,16(5):64.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(3):64.
[2]王丽萍,陈建,庄永泽,等.IgA肾病血瘀证与肾脏病理损害的关系研究[J].中国中医药信息杂志,2008,15(1):21.
 WANG Li-ping,CHEN Jian,ZHUANG Yong-ze,et al.Study on the Relationship between Blood Stasis Syndrome and Clinical Pathology in IgA Nephropathy Patients[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):21.
[3]李建忠,华强.IgA肾病血尿中医用药规律的文献研究[J].中国中医药信息杂志,2011,18(6):29.[doi:10.3969/j.issn.1005-5304.2011.06.013]
 LI Jian-zhong,HUA Qiang.Literature Study of Chinese Medicine in Treating IgA Nephropathy Hematuria[J].zhongguo zhongyiyao xinxi zazhi,2011,18(3):29.[doi:10.3969/j.issn.1005-5304.2011.06.013]
[4]张建春,卢志远,包红梅,等.中药组方治疗IgA肾病56例疗效观察[J].中国中医药信息杂志,2007,14(9):64.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):64.
[5]刘建华,曾金雄,曾玲,等.芪莲茅根汤治疗IgA肾病大鼠的实验研究[J].中国中医药信息杂志,2006,13(1):28.
 LIU Jian-hua,ZENG Jin-xiong,ZENG Lin,et al.Study on the Effects of Qilianmaogentang on the Experimental IgA Nephropathy Rat[J].zhongguo zhongyiyao xinxi zazhi,2006,13(3):28.
[6]陈明,万廷信,戴恩来.IgA肾病中医证候分型与临床及病理的相关性[J].中国中医药信息杂志,2013,20(3):19.[doi:10.3969/j.issn.1005-5304.2013.03.009]
 CHEN Ming,WAN Ting-xin,DAI En-lai.Relevance of TCM Syndrome Types of Primary IgA Nephropathy with Clinical Manifestation and Pathological Changes[J].zhongguo zhongyiyao xinxi zazhi,2013,20(3):19.[doi:10.3969/j.issn.1005-5304.2013.03.009]
[7]曾安平,孙 伟,王 钢,等.健肾片对IgA肾病模型大鼠肾组织一氧化氮、 一氧化氮合酶含量的影响[J].中国中医药信息杂志,2004,11(3):212.
 ZENG An-ping,SUN Wei,WANG Gang,et al.Effects of Jianshen Tablet on NO and NOS in the Renal Tissue in the Rat with IgAN[J].zhongguo zhongyiyao xinxi zazhi,2004,11(3):212.
[8]徐建龙,指导:聂莉芳.基于关联规则的聂莉芳教授治疗IgA肾病用药规律分析[J].中国中医药信息杂志,2010,17(4):96.
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(3):96.
[9]李 侠,孙文英,高俊杰.毛细血管内增生性IgA肾病治疗心得[J].中国中医药信息杂志,2005,12(8):80.
[10]郑艳辉,孙 伟.伴有咽喉症状的IgA肾病的辨证治疗[J].中国中医药信息杂志,2005,12(12):80.

备注/Memo

基金项目:国家自然科学基金(81973675);北京市科学技术委员会首都临床特色应用研究(Z181100001718123)

更新日期/Last Update:

2020-02-23